Genovese Burford & Brothers Wealth & Retirement Plan Management’s GSK GSK Stock Holding History

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-338	Closed	-$17K	–	197
2018 Q2	$17K	Buy	338 +1	+0.3%	+$50	0.01%	265
2018 Q1	$16K	Hold	337	–	–	0.01%	275
2017 Q4	$16K	Buy	337 +61	+22%	+$2.82K	0.04%	158
2017 Q3	$14K	Hold	276	–	–	0.01%	260
2017 Q2	$14K	Hold	276	–	–	0.01%	251
2017 Q1	$15K	Buy	276 +42	+18%	+$2.13K	0.01%	262
2016 Q4	$12K	Hold	234	–	–	﹤0.01%	301
2016 Q3	$12K	Hold	234	–	–	﹤0.01%	280
2016 Q2	$12K	Buy	234 +38	+19%	+$2K	﹤0.01%	261
2016 Q1	$9K	Hold	196	–	–	﹤0.01%	270
2015 Q4	$10K	Buy	+196	New	+$9.99K	﹤0.01%	250

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Genovese Burford & Brothers Wealth & Retirement Plan Management's GSK Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of GSK (GSK) in Q3 2018, closing a stake of 338 shares — an estimated $17K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in GSK in Q4 2015 and held it in 11 quarters. The position peaked at $17K in Q2 2018. 788 funds tracked by Wall St. Rank hold GSK as of Q3 2018.

Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining GSK position as of Q3 2018 after selling out during the quarter.
Genovese Burford & Brothers Wealth & Retirement Plan Management sold 338 GSK shares in Q3 2018, an estimated $17K.
Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in GSK in Q4 2015 and held it in 11 quarters.
Genovese Burford & Brothers Wealth & Retirement Plan Management's GSK position peaked at $17K in Q2 2018.
788 funds tracked by Wall St. Rank held GSK as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.